Carmen María Évora García-rekin lankidetzan egindako argitalpenak (24)

2014

  1. Cartilage repair by local delivery of transforming growth factor-β1 or bone morphogenetic protein-2 from a novel, segmented polyurethane/polylactic- co-glycolic bilayered scaffold

    Journal of Biomedical Materials Research - Part A, Vol. 102, Núm. 4, pp. 1110-1120

  2. Repair of an osteochondral defect by sustained delivery of BMP-2 or TGFβ1 from a bilayered alginate-PLGA scaffold

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 8, Núm. 7, pp. 521-533

2012

  1. A platelet derived growth factor delivery system for bone regeneration

    Journal of Materials Science: Materials in Medicine, Vol. 23, Núm. 8, pp. 1903-1912

  2. Comparative, osteochondral defect repair: Stem cells versus chondrocytes versus bone morphogenetic protein-2, solely or in combination

    European Cells and Materials, Vol. 25, pp. 351-365

  3. Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect

    Injury, Vol. 43, Núm. 3, pp. 334-342

  4. In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system

    Journal of Biomedical Materials Research - Part A, Vol. 100 A, Núm. 9, pp. 2382-2391

  5. Material-related effects of BMP-2 delivery systems on bone regeneration

    Acta Biomaterialia, Vol. 8, Núm. 2, pp. 781-791

2010

  1. Reticulated vitreous carbon: A useful material for cell adhesion and tissue invasion

    European Cells and Materials, Vol. 20, pp. 282-294

2009

  1. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 73, Núm. 1, pp. 50-58

2008

  1. Efficacy of ciprofloxacin implants in treating experimental osteomyelitis

    Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 85, Núm. 1, pp. 93-104

2006

  1. Biodegradable implantable fluconazole delivery rods designed for the treatment of fungal osteomyelitis: Influence of gamma sterilization

    Journal of Biomedical Materials Research - Part A, Vol. 77, Núm. 3, pp. 632-638

  2. Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone

    Journal of Controlled Release, Vol. 114, Núm. 2, pp. 223-229

2005

  1. Two-month ciprofloxacin implants for multibacterial bone infections

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 60, Núm. 3, pp. 401-406

2003

  1. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization

    Journal of Controlled Release, Vol. 93, Núm. 3, pp. 341-354

2002

  1. In vitro-in vivo characterization of gentamicin bone implants

    Journal of Controlled Release, Vol. 83, Núm. 3, pp. 353-364

2001

  1. In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 52, Núm. 2, pp. 151-158

2000

  1. Radiolabelled biodegradable microspheres for lung imaging

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Núm. 2, pp. 227-236

1992

  1. Effect of humidity and packaging on the long-term aging of commercial sustained-release theophylline tablets

    International Journal of Pharmaceutics, Vol. 83, Núm. 1-3, pp. 59-63

1990

  1. A new approach to pharmacokinetic parameters: Estimation of cefuroxime during haemodialysis

    Biopharmaceutics & Drug Disposition, Vol. 11, Núm. 2, pp. 107-120

  2. EFECTO DE LOS ALIMENTOS SOBRE LA BIODISPONIBILIDAD DE TEOFILINA EN FORMULACIONES DE CESION SOSTENIDA. REVISION

    Farmacia Clinica, Vol. 7, Núm. 2, pp. 150-158